TCT 416: Impact of Total Stent Length on Long-Term Clinical Outcomes With Newer-Generation Drug-Eluting Stents in ST-Segment Elevation Myocardial Infarction: A Subgroup Analysis From the Biostemi ES Randomized Trial
Presenter:
We Recommend
Disclosures
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
- Grant Support/Research Contract - Biotronik; Concept Medical; Terumo Medical Corporation; Biotronik; Concept Medical; Terumo Medical Corporation
- Consultant Fee/Honoraria/Speaker's Bureau - Biotronik; Concept Medical; Medtronic; Cordis Corporation, a Johnson & Johnson company; Penumbra; Recor Medical; Biotronik; Concept Medical; Medtronic; Cordis Corporation, a Johnson & Johnson company; Penumbra; Recor Medical